MEDCLUERX Trademark

Trademark Overview

On Tuesday, August 30, 2016, a trademark application was filed for MEDCLUERX with the United States Patent and Trademark Office. The USPTO has given the MEDCLUERX trademark a serial number of 87155578. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, March 22, 2024. This trademark is owned by NorthShore University HealthSystem. The MEDCLUERX trademark is filed in the Pharmaceutical Products category with the following description:

Genomic tests for medical or clinical purposes, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes; genomic tests for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans; kits for use in genetic testing for medical or clinical purposes, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes; kits for use in genetic testing for medical or clinical purposes in DNA testing of humans, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes in DNA testing of humans
medcluerx

General Information

Serial Number87155578
Word MarkMEDCLUERX
Filing DateTuesday, August 30, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 22, 2024
Registration Number5434168
Registration DateTuesday, March 27, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2017

Trademark Statements

Goods and ServicesGenomic tests for medical or clinical purposes, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes; genomic tests for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans; kits for use in genetic testing for medical or clinical purposes, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes; kits for use in genetic testing for medical or clinical purposes in DNA testing of humans, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes in DNA testing of humans
Pseudo MarkMED CLUE RX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 3, 2017
Primary Code005
First Use Anywhere DateThursday, January 12, 2017
First Use In Commerce DateThursday, January 12, 2017

Trademark Owner History

Party NameNorthShore University HealthSystem
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWarrenville, IL 60555
Party NameNorthShore University HealthSystem
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEvanston, IL 60201
Party NameNorthShore University HealthSystem
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEvanston, IL 60201

Trademark Events

Event DateEvent Description
Friday, March 22, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 22, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 27, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 10, 2018REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Wednesday, May 2, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 27, 2018REGISTERED-PRINCIPAL REGISTER
Friday, February 23, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 22, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, January 29, 2018USE AMENDMENT FILED
Friday, February 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 29, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, January 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 12, 2017ASSIGNED TO LIE
Saturday, September 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 21, 2017NON-FINAL ACTION E-MAILED
Monday, August 21, 2017NON-FINAL ACTION WRITTEN
Friday, August 18, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 27, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, June 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION WRITTEN
Thursday, December 8, 2016ASSIGNED TO EXAMINER
Wednesday, September 7, 2016NOTICE OF PSEUDO MARK E-MAILED
Tuesday, September 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

medcluerx purposes medical clinical testing genomic kits humans reagents comprised namely